Strong Growth in Subscription-Based Recurring Revenue Continues for Healthy
Extracts as Category Top Three Amazon Seller
LAS VEGAS, October 17, 2024 — Healthy Extracts Inc. (OTCQB: HYEX), a platform for acquiring, developing,
patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories
within the multibillion-dollar nutraceuticals market, reported preliminary record results for the third
quarter ended September 30, 2024.
Net revenue is expected to exceed $740,000, a record for a third quarter, up more than 20% compared to
the same year-ago quarter.
Gross margin for the quarter is expected to exceed 80%, driving positive operating cash flow and net
profitability.
“In Q3, we achieved another quarter of record-breaking revenue, continued margin improvements, and
further debt reduction, with this driven by robust performance in our direct-to-consumer channels,”
stated Healthy Extracts president, Duke Pitts. “This consistent growth momentum with our key retail
customers positions us for the successful launch of new products we are planning to introduce in the
current quarter.”
The company generated record sales on Amazon in July, primarily as a result of its focused sales and
marketing efforts for Prime Day and increased demand for its “Subscribe & Save” offers. During the
quarter, the company continued to rank as a top three seller of Citrus Bergamot on Amazon among more
than 100 competitors.
The company’s products feature the only heart health supplement distributed in North America containing
Citrus Bergamot SuperFruit™, which has the highest known concentration of polyphenols and flavonoids.
Given the success with Amazon’s “Subscribe and Save,” in July Healthy Extracts replaced its traditional
buy-2-get-1 offers on its eCommerce website with a 20% discount for subscribing to monthly shipments.
“We expect this move to increase sales and margins, as well as the lifetime value of our customers due to
improved customer retention,” noted Pitts. “In fact, the new offer has been well received, generating a
significant increase in overall subscriber growth during the first several weeks.”
Looking ahead, the company anticipates strengthening performance in top-line growth, profitability, and
market share expansion as its addressable markets continue to grow. This positive outlook is largely due
to the anticipated launch of new products that will benefit from the broad market channels the company
has strategically developed and invested in over the past several years.
According to Pitts, “These investments have proven to be the most effective way to create significant
shareholder value—and this will continue to be our top priority.”
The preliminary unaudited results presented in this press release are estimates only and are subject to
revision until the company officially reports its quarterly results in mid-November.
About Healthy Extracts “Live Life Young Again”
Healthy Extracts Inc. is a platform for acquiring, developing, researching, patenting, marketing, and
distributing plant-based nutraceuticals.
The company’s subsidiaries, BergametNA™ and Ultimate Brain Nutrients™ (UBN), offer nutraceutical
natural heart and brain health supplements. This includes the only heart health supplement distributed in
North America containing Citrus Bergamot SuperFruit™. This superfruit has the highest known
concentration of polyphenols and flavonoids.
UBN’s KETONOMICS® proprietary formulations, which have been designed to enhance brain activity,
focus, headache and cognitive behavior, provide many sales and intellectual property licensing
opportunities.
For more information visit: healthyextractsinc.com, bergametna.com or tryubn.com.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are “forward-looking
statements” (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking
statements include our expectations and those statements that use forward-looking words such as
“projected,” “expect,” “possibility” and “anticipate.” The achievement or success of the matters covered
by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results
could differ materially from current projections or implied results. Investors should read the risk factors
set forth in the Company’s Annual Report on Form 10-K filed with the SEC on April 1, 2024, and future
periodic reports filed with the SEC. All of the Company’s forward-looking statements are expressly
qualified by all such risk factors and other cautionary statements. The Company cautions that statements
and assumptions made in this news release constitute forward-looking statements and make no
guarantee of future performance. Forward-looking statements are based on estimates and opinions of
management at the time statements are made. The information set forth herein speaks only as of the date
hereof. The Company and its management undertake no obligation to revise these statements following
the date of this news release.
Food and Drug Administration Disclosure
The product and formulation featured in this release is not for use by or sale to persons under the age of
12. This product should be used only as directed on the label. Consult with a physician before use if you
have a serious medical condition or use prescription medications. A doctor’s advice should be sought
before using this and any supplemental dietary product. These statements have not been evaluated by the
FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are registered
trademarks of Healthy Extracts Inc.™
Company Contact
Duke Pitts, President
Healthy Extracts Inc.
Tel (720) 463-1004
Email contact
Investor Contact:
Ronald Both
CMA Investor Relations
Tel (949) 432-7566
Email contact